Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: Co-mutations of TP53 and KRAS serve as potential biomarkers for immune checkpoint blockade in squamous-cell non-small cell lung cancer: a case report

Fig. 2

CT scans of the patient. a, b, c CT scan after four cycles of adjuvant chemotherapy with paclitaxel and carboplatin in August 2017. None metastases were observed in the lung or mediastinal lymph node. d, e, f CT scan 5 months after adjuvant chemotherapy, from which many new lung metastases in the entire lung were noted. g, h, i CT scan after two cycles of rh-endostain and docetaxel chemotherapy. The lung metastases became evidently larger

Back to article page